<DOC>
	<DOC>NCT00330850</DOC>
	<brief_summary>The purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura. The study is also intended to show the effectiveness of PRO-513 for associated symptoms of nausea, photophobia, and phonophobia due to a migraine attack.</brief_summary>
	<brief_title>An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Photophobia</mesh_term>
	<mesh_term>Hyperacusis</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Male and Female subjects 1865 years of age Primary diagnosis of migraine attack with aura or migraine attack without aura Migraine history of averaging at least 1 migraine attack per month but averaging not more than 6 migraine attacks per month over the prior year Female subjects must use an effective form of birth control Listing of additional inclusion criteria are available through the Sponsor Excluding subjects with a history of other serious events causing secondary headaches Excluding subjects with a current medical condition that could interfere with the overall study intent or affect the absorption, distribution, metabolism, or excretion of the study medication Excluding subjects with a history or current medical condition that could confound the study results or use of a concomitant medication that could interfere with the study drug Listing of additional exclusion criteria are available through the Sponsor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Photophobia</keyword>
	<keyword>Phonophobia</keyword>
	<keyword>Aura</keyword>
</DOC>